Does the Bacillus Calmette–Guérin vaccine provide protection from COVID-19?
Author:
Open Access
- 30 April 2020
- journal article
- research article
- Published by Scientific Scholar in Indian Journal of Medical Sciences
- Vol. 72 (1) , 17-20
Abstract
Objective: The novel coronavirus pandemic is ravaging throughout the world. It has infected more than 1.2 million people and killed more than 64,000. Frantic research is underway to find prevention and cure. Of late, Bacillus Calmette–Guérin (BCG) has been speculated as a possible protection from COVID-19. We sought to investigate the evidence behind the claim. Material and Methods: Data were collected regarding the total number of COVID-19 cases per million and total number of COVID-19 deaths per million in various countries. The BCG vaccination policies of these countries were also obtained. Results: It was seen that the countries with no universal BCG policy had a mean 1272.9 (median 795) cases per million and 80.7 deaths (median 18) per million population. On the contrary, the countries with a universal BCG vaccination policy had a mean 131.2 (median 40) cases per million and 4 deaths (median 1) per population. The difference is highly significant (P < 0.001). Conclusion: The data strongly support the hypothesis that BCG may offer protection from COVID-19. Heterologous protection offered by BCG through production of trained immunity, epigenetic reprogramming of monocytes, non-specific activation of NK cells, and increase of pro-inflammatory cytokines (particularly, tumor necrosis factor [TNF]-alpha and interleukin 1 beta) production may be the mechanism behind its cross- protection against the novel coronavirus.Keywords
This publication has 7 references indexed in Scilit:
- New live attenuated tuberculosis vaccine MTBVAC induces trained immunity and confers protection against experimental lethal pneumoniaPLOS Pathogens, 2020
- Non-specific effects of BCG vaccine on viral infectionsClinical Microbiology and Infection, 2019
- Targeting innate immunity for tuberculosis vaccinationJournal of Clinical Investigation, 2019
- Trained immunity: A program of innate immune memory in health and diseaseScience, 2016
- Long-Lasting Effects of BCG Vaccination on Both Heterologous Th1/Th17 Responses and Innate Trained ImmunityJournal of Innate Immunity, 2013
- Quiescent haematopoietic stem cells are activated by IFN-γ in response to chronic infectionNature, 2010
- Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa Commentary: an unexpected finding that needs confirmation or rejectionBMJ, 2000